- Home
- QLGN vs SXTP Comparison
QLGN vs SXTP Comparison
Compare QLGN & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QLGN
- SXTP
- Stock Information
- Founded
- QLGN 1996
- SXTP 2010
- Country
- QLGN United States
- SXTP United States
- Employees
- QLGN N/A
- SXTP N/A
- Industry
- QLGN Biotechnology: Pharmaceutical Preparations
- SXTP Biotechnology: Pharmaceutical Preparations
- Sector
- QLGN Health Care
- SXTP Health Care
- Exchange
- QLGN Nasdaq
- SXTP Nasdaq
- Market Cap
- QLGN 2.4M
- SXTP 2.4M
- IPO Year
- QLGN N/A
- SXTP 2023
- Fundamental
- Price
- QLGN $3.55
- SXTP $0.45
- Analyst Decision
- QLGN
- SXTP Hold
- Analyst Count
- QLGN 0
- SXTP 1
- Target Price
- QLGN N/A
- SXTP N/A
- AVG Volume (30 Days)
- QLGN 110.9K
- SXTP 5.8M
- Earning Date
- QLGN 04-07-2025
- SXTP 03-31-2025
- Dividend Yield
- QLGN N/A
- SXTP N/A
- EPS Growth
- QLGN N/A
- SXTP N/A
- EPS
- QLGN N/A
- SXTP N/A
- Revenue
- QLGN N/A
- SXTP $462,612.00
- Revenue This Year
- QLGN N/A
- SXTP $141.35
- Revenue Next Year
- QLGN N/A
- SXTP $175.16
- P/E Ratio
- QLGN N/A
- SXTP N/A
- Revenue Growth
- QLGN N/A
- SXTP 128.99
- 52 Week Low
- QLGN $2.96
- SXTP $0.41
- 52 Week High
- QLGN $29.45
- SXTP $7.20
- Technical
- Relative Strength Index (RSI)
- QLGN 47.06
- SXTP 33.01
- Support Level
- QLGN $3.16
- SXTP $0.47
- Resistance Level
- QLGN $3.75
- SXTP $0.67
- Average True Range (ATR)
- QLGN 0.21
- SXTP 0.10
- MACD
- QLGN 0.06
- SXTP 0.00
- Stochastic Oscillator
- QLGN 67.25
- SXTP 12.96
About QLGN Qualigen Therapeutics Inc.
Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.